药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cefotetan
Dabigatran
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Dabigatran.
Cefotetan
Edetate calcium disodium anhydrous
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Edetate calcium disodium anhydrous.
Cefotetan
Tocopherylquinone
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Tocopherylquinone.
Cefotetan
(S)-Warfarin
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with (S)-Warfarin.
Cefotetan
Saruplase
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Saruplase.
Cefotetan
Melagatran
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Melagatran.
Cefotetan
Tioclomarol
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Tioclomarol.
Cefotetan
Diphenadione
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Diphenadione.
Cefotetan
Clorindione
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Clorindione.
Cefotetan
Brinase
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Brinase.
Cefotetan
Protein S human
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Protein S human.
Cefotetan
Fluindione
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Fluindione.
Cefotetan
Gabexate
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Gabexate.
Cefotetan
Monteplase
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Monteplase.
Cefotetan
Nafamostat
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Nafamostat.
Cefotetan
Betrixaban
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Betrixaban.
Cefotetan
Darexaban
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Darexaban.
Cefotetan
Letaxaban
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Letaxaban.
Cefotetan
Antithrombin III human
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Antithrombin III human.
Cefotetan
Protein C
The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Protein C.